Switching from one generic methylphenidate manufacturer to another: is that actually a meaningful change?

For most people, no, generics must meet Health Canada's bioequivalence standards and are expected to work the same as the brand or other generic versions. Where a difference can show up is specifically in extended-release formulations, where the release mechanism, not the active drug itself, can vary slightly between manufacturers. A small number of people do notice a real difference switching between generic manufacturers of the same extended-release medication, often described as the coverage feeling less smooth or wearing off at a different time, which is worth raising with a pharmacist or prescriber if it happens rather than assumed to be in someone's head. If the change is persistent, distressing, or affecting daily functioning, contact your provider through the FasTreat portal rather than changing medication on your own. Related reading: https://www.fastreat.com/en/blogs/adhd-medication References: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/bioequivalence-requirements.html

Switched pharmacies once and got a different manufacturer's version without realizing. Noticed it wore off about an hour earlier than usual for a couple weeks until I got used to it. Wish I'd known to expect that specific timeline going in, since I spent the first stretch assuming something had gone wrong. Would recommend asking your prescriber upfront exactly what week-by-week progress is supposed to look like, so you have something concrete to measure against instead of just guessing.